Tumor-driven stabilization of CD8+ T cell exhaustion and implications for cancer immunotherapy - Top-Institutions - MDSpire

Tumor-driven stabilization of CD8+ T cell exhaustion and implications for cancer immunotherapy

  • By

  • Romane Thouenon

  • Marco Ongaro

  • Grégory Verdeil

  • June 26, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Oncology
    • Immunotherapy

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, New York

    Key Differentiators

    • Oncology
    • Immunotherapy

  • #3

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, Massachusetts

    Key Differentiators

    • Oncology
    • Immunotherapy

  • #4

    Center for Cancer Immune Therapy, Herlev Hospital
    Center for Cancer Immune Therapy, Herlev Hospital

    Herlev, Denmark

    Key Differentiators

    • Oncology
    • Immunotherapy

  • #5

    Herlev and Gentofte Hospital Research Council
    Herlev and Gentofte Hospital Research Council

    Herlev, Denmark

    Key Differentiators

    • Oncology
    • Immunotherapy

Original Source(s)

Tumor-driven stabilization of CD8+ T cell exhaustion and implications for cancer immunotherapy

  • by Romane Thouenon, Marco Ongaro, Grégory Verdeil

  • June 26, 2026

Related Content

ESMO Breast Cancer 2026 Highlights: SERENA-6

Harold Burstein, MD, PhD, and Erica Mayer, MD, MPH discuss results from the SERENA-6 trial, which were presented at the 2026 ESMO Breast Cancer Congress.

  • June 26, 2026

  • 1 min
Management challenges in metachronous bilateral breast cancer with discordant receptor status: a case report

Editorial: EBV strategies to counteract the immune response